Novartis
NVS
#52
Rank
$223.35 B
Marketcap
$110.32
Share price
0.35%
Change (1 day)
6.19%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Revenue for Novartis (NVS)

Revenue in 2024 (TTM): $48.86 B

According to Novartis's latest financial reports the company's current revenue (TTM) is $48.86 B. In 2023 the company made a revenue of $46.66 B a decrease over the years 2022 revenue that were of $49.76 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novartis from 2001 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $48.86 B4.71%
2023 $46.66 B-6.25%
2022 $49.76 B-5.88%
2021 $52.87 B5.97%
2020 $49.89 B2.51%
2019 $48.67 B1.69%
2018 $47.86 B-4.53%
2017 $50.13 B1.41%
2016 $49.43 B-1.89%
2015 $50.38 B-6.05%
2014 $53.63 B-3.8%
2013 $55.75 B-3.14%
2012 $57.56 B-3.06%
2011 $59.37 B15.15%
2010 $51.56 B14.32%
2009 $45.10 B5.92%
2008 $42.58 B9.86%
2007 $38.76 B10.75%
2006 $35.00 B7.85%
2005 $32.45 B14.89%
2004 $28.24 B13.61%
2003 $24.86 B6.62%
2002 $23.32 B19.8%
2001 $19.46 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$61.40 B 25.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$55.09 B 12.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$89.65 B 83.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$50.51 B 3.38%๐Ÿ‡ซ๐Ÿ‡ท France
$38.54 B-21.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
$16.00 B-67.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$45.53 B-6.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$40.32 B-17.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$47.61 B-2.56%๐Ÿ‡ฌ๐Ÿ‡ง UK